AQUIPTA® (Atogepant) ABBVIE HK Reg. No. HK-68287 (03 Jul, 2024) & HK-68288 (03 Jul, 2024) Composition: 1 Aquipta® (Atogepant) is an orally administered, small molecule, selective calcitonin gene-related peptide (CGRP) receptor antagonist...

AMOROLFINE® (Amorolfine hydrochloride) NOVARTIS HK-68364 (09 Sept, 2024) Composition: 3 AMOROLFINE® (amorolfine hydrochloride) is a topical antimycotic. Amorolfine belongs to a new chemical class, and its fungicidal action is based on an alt...

LEQEMBI® (lecanemab) EISAI HK Reg. No. HK-68289 (03 Jul, 2024) & HK-68290 (03 Jul, 2024) Composition: 3 LEQEMBI® is an amyloid beta-directed antibody with the active ingredient lecanemab-irmb. It is administered as an intravenous infusio...

AKEEGA™ (niraparib and abiraterone acetate) JOHNSON & JOHNSON HK Reg. No. HK-68296 (09 Jul, 2024) & HK-68295 (09 Jul, 2024) Composition: 2 AKEEGA™ is a combination of niraparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, an...

LITFULO™ (ritlecitinib) PFIZER HK Reg. No. HK-68283 (28 Jun, 2024) Composition: 4 LITFULO™ is a kinase inhibitor available in the form of capsule with 50 mg ritlecitinib. Indication: 4 LITFULO™ is indicated for the treatment of sev...

AREXVY (respiratory syncytial virus vaccine, adjuvanted) GLAXOSMITHKLINE Indications: AREXVY is indicated for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in individuals 60 ...